Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (131-140 of 195) with videos related to

Pageof 20
Sort By:
Blood|September 1, 1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2J C Biggs, J Szer, P Crilley, et al.
Bone Marrow Transplantation|January 1, 1995
Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study GroupJ C Biggs, K A Atkinson, V Booker, et al.
Bone Marrow Transplantation|March 7, 2006
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateN Murphy, M Diviney, J Szer, et al.
Internal Medicine Journal|December 9, 2014
Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014M A Slavin, K A Thursky, L J Worth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignanciesE J Bow, C Rotstein, G A Noskin, et al.
Seminars in Oncology|August 1, 1993
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an updateI Brodsky, J C Biggs, J Szer, et al.
Internal Medicine Journal|July 1, 2008
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancyM A Slavin, C H Heath, K A Thursky, et al.
Internal Medicine Journal|May 25, 2010
Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005I Nivison-Smith, A J Dodds, H Dunckley, et al.
Lancet (London, England)|March 14, 1992
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyW P Sheridan, C G Begley, C A Juttner, et al.
Bone Marrow Transplantation|August 11, 2001
Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrowI Nivison-Smith, K F Bradstock, J Szer, et al.
Pageof 20

Showing results (131-140 of 195) with videos related to

Sort By:
Pageof 20
Blood|September 1, 1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2J C Biggs, J Szer, P Crilley, et al.
Bone Marrow Transplantation|January 1, 1995
Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study GroupJ C Biggs, K A Atkinson, V Booker, et al.
Bone Marrow Transplantation|March 7, 2006
Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateN Murphy, M Diviney, J Szer, et al.
Internal Medicine Journal|December 9, 2014
Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014M A Slavin, K A Thursky, L J Worth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignanciesE J Bow, C Rotstein, G A Noskin, et al.
Seminars in Oncology|August 1, 1993
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an updateI Brodsky, J C Biggs, J Szer, et al.
Internal Medicine Journal|July 1, 2008
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancyM A Slavin, C H Heath, K A Thursky, et al.
Internal Medicine Journal|May 25, 2010
Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005I Nivison-Smith, A J Dodds, H Dunckley, et al.
Lancet (London, England)|March 14, 1992
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyW P Sheridan, C G Begley, C A Juttner, et al.
Bone Marrow Transplantation|August 11, 2001
Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrowI Nivison-Smith, K F Bradstock, J Szer, et al.
Pageof 20